Brief: Oncopeptides: Rights Issue Oversubscribed To About 157 Percent
Sept 17 (Reuters) - Oncopeptides AB ONCO.ST: ONCOPEPTIDES’ RIGHTS ISSUE OVERSUBSCRIBED TO APPROXIMATELY 157 PERCENT 93% OF OFFERED SHARES SUBSCRIBED IN RIGHTS ISSUE 64% OF OFFERED SHARES APPLIED WITHOUT SUBSCRIPTION RIGHTS RIGHTS ISSUE TO PROVIDE SEK 150 MILLION BEFORE COSTS Source text: ID:nMFN94Ysn4 Further company coverage: ONCO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy